Increased Expression of Cyclooxygenase-2 is Associated with the Progression to Cirrhosis
![]() |
Jeong, Soung-Won
(Institute for Digestive Research and Digestive Disease Center, Soonchunhyang University College of Medicine)
Jang, Jae-Young (Institute for Digestive Research and Digestive Disease Center, Soonchunhyang University College of Medicine) Lee, Sae-Hwan (Institute for Digestive Research and Digestive Disease Center, Soonchunhyang University College of Medicine) Kim, Sang-Gyun (Institute for Digestive Research and Digestive Disease Center, Soonchunhyang University College of Medicine) Cheon, Young-Koog (Institute for Digestive Research and Digestive Disease Center, Soonchunhyang University College of Medicine) Kim, Young-Seok (Institute for Digestive Research and Digestive Disease Center, Soonchunhyang University College of Medicine) Cho, Young-Deok (Institute for Digestive Research and Digestive Disease Center, Soonchunhyang University College of Medicine) Kim, Hong-Soo (Institute for Digestive Research and Digestive Disease Center, Soonchunhyang University College of Medicine) Lee, Joon-Seong (Institute for Digestive Research and Digestive Disease Center, Soonchunhyang University College of Medicine) Jin, So-Young (Department of Pathology, Soonchunhyang University College of Medicine) Shim, Chan-Sup (Department of Internal Medicine, Konkuk University School of Medicine) Kim, Boo-Sung (Institute for Digestive Research and Digestive Disease Center, Soonchunhyang University College of Medicine) |
1 | Denda A, Endoh T, Kitayama W, et al. Inhibition by piroxicam of oxidative DNA damage, liver cirrhosis and development of enzyme-altered nodules caused by a choline-deficient, L-amino acid-defined diet in rats. Carcinogenesis 1997;18:1921-1930. DOI ScienceOn |
2 | Cheng AS, Chan HL, Leung NW, et al. Expression of cyclooxygenase-2 in chronic hepatitis B and the effects of antiviral therapy. Aliment Pharmacol Ther 2002;16:251-260. DOI ScienceOn |
3 | Pazirandeh S, Khettry U, Gordon FD, Resnick RH, Murray JE, Sheth SG. Cyclooxygenase-2 expression in hepatocellular carcinoma, cirrhosis and chronic hepatitis in the United States. Dig Dis Sci 2007;52:220-227. DOI ScienceOn |
4 | Planagumà A, Clària J, Miquel R, et al. The selective cyclooxygenase-2 inhibitor SC-236 reduces liver fibrosis by mechanisms involving non-parenchymal cell apoptosis and PPARgamma activation. FASEB J 2005;19:1120-1122. DOI |
5 | Ishak K, Baptista A, Bianchi L, et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995;22:696-699. DOI ScienceOn |
6 | Qiu DK, Ma X, Peng YS, Chen XY. Significance of cyclooxygenase-2 expression in human primary hepatocellular carcinoma. World J Gastroenterol 2002;8:815-817. DOI |
7 | Morinaga S, Yamamoto Y, Noguchi Y, et al. Cyclooxygenase-2 mRNA is up-regulated in cirrhotic or chronic hepatitis liver adjacent to hepatocellular carcinoma. J Gastroenterol Hepatol 2002;17:1110-1116. DOI ScienceOn |
8 | Yu J, Hui AY, Chu ES, et al. Expression of a cyclo-oxygenase-2 transgene in murine liver causes hepatitis. Gut 2007;56:991-999. DOI ScienceOn |
9 | Vanchieri C. Vioxx withdrawal alarms cancer prevention researchers. J Natl Cancer Inst 2004;96:1734-1735. DOI ScienceOn |
10 | Mallat A, Gallois C, Tao J, et al. Platelet-derived growth factor-BB and thrombin generate positive and negative signals for human hepatic stellate cell proliferation. Role of a prostaglandin/cyclic AMP pathway and cross-talk with endothelin receptors. J Biol Chem 1998;273:27300-27305. DOI ScienceOn |
11 | Failli P, DeFranco RM, Caligiuri A, et al. Nitrovasodilators inhibit platelet-derived growth factor-induced proliferation and migration of activated human hepatic stellate cells. Gastroenterology 2000;119:479-492. DOI ScienceOn |
12 | Hui AY, Leung WK, Chan HL, et al. Effect of celecoxib on experimental liver fibrosis in rat. Liver Int 2006;26:125-136. DOI ScienceOn |
13 | Reilly TP, Brady JN, Marchick MR, et al. A protective role for cyclooxygenase-2 in drug-induced liver injury in mice. Chem Res Toxicol 2001;14:1620-1628. DOI ScienceOn |
14 |
Yu J, Wu CW, Chu ES, et al. Elucidation of the role of |
15 | Yamamoto H, Kondo M, Nakamori S, et al. JTE-522, a cyclooxygenase-2 inhibitor, is an effective chemopreventive agent against rat experimental liver fibrosis1. Gastroenterology 2003;125:556-571. DOI ScienceOn |
16 | Tu CT, Guo JS, Wang M, Wang JY. Antifibrotic activity of rofecoxib in vivo is associated with reduced portal hypertension in rats with carbon tetrachloride-induced liver injury. J Gastroenterol Hepatol 2007;22:877-884. DOI ScienceOn |
17 | Radaeva S, Li Y, Hacker HJ, Burger V, Kopp-Schneider A, Bannasch P. Hepadnaviral hepatocarcinogenesis: in situ visualization of viral antigens, cytoplasmic compartmentation, enzymic patterns, and cellular proliferation in preneoplastic hepatocellular lineages in woodchucks. J Hepatol 2000;33:580-600. DOI ScienceOn |
18 | Huang SN, Chisari FV. Strong, sustained hepatocellular proliferation precedes hepatocarcinogenesis in hepatitis B surface antigen transgenic mice. Hepatology 1995;21:620-626. |
19 | Dunsford HA, Sell S, Chisari FV. Hepatocarcinogenesis due to chronic liver cell injury in hepatitis B virus transgenic mice. Cancer Res 1990;50:3400-3407. |
20 | Ueno Y, Moriyama M, Uchida T, Arakawa Y. Irregular regeneration of hepatocytes is an important factor in the hepatocarcinogenesis of liver disease. Hepatology 2001;33:357-362. DOI ScienceOn |
21 | Hu KQ. Rationale and feasibility of chemoprovention of hepatocellular carcinoma by cyclooxygenase-2 inhibitors. J Lab Clin Med 2002;139:234-243. DOI ScienceOn |
22 |
Cheng AS, Chan HL, Leung WK, et al. Expression of HBx and |
23 | Gallois C, Habib A, Tao J, et al. Role of NF-kappaB in the antiproliferative effect of endothelin-1 and tumor necrosis factoralpha in human hepatic stellate cells. Involvement of cyclooxygenase-2. J Biol Chem 1998;273:23183-23190. DOI ScienceOn |
24 | Gupta S, Srivastava M, Ahmad N, Bostwick DG, Mukhtar H. Over-expression of cyclooxygenase-2 in human prostate adenocarcinoma. Prostate 2000;42:73-78. DOI ScienceOn |
25 | Koga H, Sakisaka S, Ohishi M, et al. Expression of cyclooxygenase-2 in human hepatocellular carcinoma: relevance to tumor dedifferentiation. Hepatology 1999;29:688-696. DOI ScienceOn |
26 |
Ochiai M, Oguri T, Isobe T, Ishioka S, Yamakido M. Cyclooxygenase-2 |
27 | Agrawal A, Fentiman IS. NSAIDs and breast cancer: a possible prevention and treatment strategy. Int J Clin Pract 2008;62:444-449. DOI ScienceOn |
28 |
Kondo M, Yamamoto H, Nagano H, et al. Increased expression of |
29 | Shiota G, Okubo M, Noumi T, et al. Cyclooxygenase-2 expression in hepatocellular carcinoma. Hepatogastroenterology 1999;46:407-412. |
30 |
Bae SH, Jung ES, Park YM, et al. Expression of cyclooxygenase- 2 |
31 | Zimmermann KC, Sarbia M, Weber AA, Borchard F, Gabbert HE, Schror K. Cyclooxygenase-2 expression in human esophageal carcinoma. Cancer Res 1999;59:198-204. |
32 | Williams CS, Mann M, DuBois RN. The role of cyclooxygenases in inflammation, cancer, and development. Oncogene 1999;18:7908-7916. DOI |
33 | Sano H, Kawahito Y, Wilder RL, et al. Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res 1995;55:3785-3789. |
34 | Dimberg J, Samuelsson A, Hugander A, Söderkvist P. Differential expression of cyclooxygenase 2 in human colorectal cancer. Gut 1999;45:730-732. DOI ScienceOn |
35 | Lim HY, Joo HJ, Choi JH, et al. Increased expression of cyclooxygenase-2 protein in human gastric carcinoma. Clin Cancer Res 2000;6:519-525. |
![]() |